Concepedia

I.J.M. Beresford

IB

Statistics

Publications

26

Citations

1.6K

H-Index

21

Active since

1986

Affiliations

University of Hertfordshire(Current)

Addenbrooke's Hospital

Age UK

Oxford Research Group

Institute of Animal Physiology of the Slovak Academy of Sciences

I.J.M. Beresford is an author at University of Hertfordshire specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1986–2014

26

Publications

26

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 300 citations

Investigation into species variants in tachykinin NK<sub>1</sub> receptors by use of the non‐peptide antagonist, CP‐96,345

I.J.M. Beresford, P.J. Birch, R.M. Hagan et al. · British Journal of Pharmacology · 1991 · 220 citations · Full text

Pharmacological characterization of human recombinant melatonin mt<sub>1</sub> and MT<sub>2</sub> receptors

Christopher R. Browning, I.J.M. Beresford, Neil J. Fraser et al. · British Journal of Pharmacology · 2000 · 132 citations · Full text

Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: New tools for investigating neurokinin function

R.M. Hagan, S.J. Ireland, Christopher Jordan et al. · Neuropeptides · 1991 · 108 citations

, , +11

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H&lt;sub&gt;3&lt;/sub&gt; Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 108 citations

1–5 of 26